Seamus Mulligan - Net Worth and Insider Trading

Seamus Mulligan Net Worth

The estimated net worth of Seamus Mulligan is at least $125 Million dollars as of 2024-04-25. Seamus Mulligan is the Director of Jazz Pharmaceuticals PLC and owns about 1,152,788 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $125 Million. Details can be seen in Seamus Mulligan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Seamus Mulligan has not made any transactions after 2020-05-27 and currently still holds the listed stock(s).

Transaction Summary of Seamus Mulligan

To

Seamus Mulligan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Seamus Mulligan owns 2 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) , and Emergent BioSolutions Inc (EBS) .

Click here to see the complete history of Seamus Mulligan’s form 4 insider trades.

Insider Ownership Summary of Seamus Mulligan

Ticker Comapny Transaction Date Type of Owner
JAZZ Jazz Pharmaceuticals PLC 2020-05-27 director
EBS Emergent BioSolutions Inc 2019-03-19 director

Seamus Mulligan Latest Holdings Summary

Seamus Mulligan currently owns a total of 1 stock. Seamus Mulligan owns 1,152,788 shares of Jazz Pharmaceuticals PLC (JAZZ) as of May 27, 2020, with a value of $125 Million.

Latest Holdings of Seamus Mulligan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JAZZ Jazz Pharmaceuticals PLC 2020-05-27 1,152,788 108.32 124,869,996

Holding Weightings of Seamus Mulligan


Seamus Mulligan Form 4 Trading Tracker

According to the SEC Form 4 filings, Seamus Mulligan has made a total of 1 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the acquisition of 50,000 shares on May 27, 2020, which cost Seamus Mulligan around $6 Million.

Insider Trading History of Seamus Mulligan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Seamus Mulligan Trading Performance

GuruFocus tracks the stock performance after each of Seamus Mulligan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Seamus Mulligan is 1.19%. GuruFocus also compares Seamus Mulligan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Seamus Mulligan within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Seamus Mulligan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Seamus Mulligan

Average Return

25.77%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.48 1.19 11.33 25.77 8.29 1.26
Relative Return to S&P 500(%) -0.65 -7.03 -0.81 -0.56 -7.54 -14.33

Seamus Mulligan Ownership Network

Ownership Network List of Seamus Mulligan

No Data

Ownership Network Relation of Seamus Mulligan


Seamus Mulligan Owned Company Details

What does Jazz Pharmaceuticals PLC do?

Who are the key executives at Jazz Pharmaceuticals PLC?

Seamus Mulligan is the director of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include VP & Finance& PAO Patricia Carr , SVP & General Counsel Neena M Patil , and director & 10 percent owner Patrick G Enright .

Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary

Over the past 18 months, Seamus Mulligan made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 6,364 shares made by Patricia Carr , a net sale of 7,360 shares made by Neena M Patil , and a net sale of 7,000 shares made by Bruce C Cozadd .

In summary, during the past 3 months, insiders sold 3,704 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 12,000 shares, with a net purchase of 8,296 shares. During the past 18 months, 64,701 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 52,701 shares.

Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jazz Pharmaceuticals PLC Insider Transactions

No Available Data

Seamus Mulligan Mailing Address

Above is the net worth, insider trading, and ownership report for Seamus Mulligan. You might contact Seamus Mulligan via mailing address: 45 Fitzwilliam Square, Dublin L2 2.

Discussions on Seamus Mulligan

No discussions yet.